Meanwhile, the appetite suppression from semaglutide remains relatively constant at the maintenance dose
Generic semaglutide does not yet exist on the market
In the future, a multidimensional line of evidence is needed to clarify the source of GLP-1RA effects in IBD, including in vitro experiments to confirm direct actions, animal models designed to exclude metabolic interference, and clinical data adjusted for metabolic confounders
And yet, results vary wildly from week to week
This is normal dose escalation response
In some cases, more severe side effects may occur, such as pancreatic inflammation, vision changes or low blood sugar, especially when taken with other diabetes medications